A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML
MEI Pharma, Inc.
MEI Pharma, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Hutchmed
Incyte Corporation
H. Lee Moffitt Cancer Center and Research Institute
Swiss Cancer Institute
M.D. Anderson Cancer Center
Incyte Corporation
Novartis
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
University of Utah
University of Miami
Novartis
Thomas Jefferson University
Thomas Jefferson University
University of California, Davis
MingSight Pharmaceuticals, Inc
Memorial Sloan Kettering Cancer Center
IGM Biosciences, Inc.